Gilles Devouassoux

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity

Vincent Cottin, Hilario Nunès, Pierre‐Yves Brillet et al. · European Respiratory Journal · 2005 · 992 citations · Full text

Advanced Lung Disease, Pathology, Pulmonary Physiology +10

Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers

Chloë I. Bloom, Christine M. Graham, Matthew Berry et al. · PLoS ONE · 2013 · 317 citations · Full text

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

Marc Decramer, Kenneth R. Chapman, Ronald Dahl et al. · The Lancet Respiratory Medicine · 2013 · 272 citations

Health Policy, Indacaterol Versus Tiotropium, Advanced Lung Disease +4

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10